These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A simple method for flow cytometric measurement of Ki-67 reactive antigen on small solid tissues]. Murakami T; Oga A; Uchiyama T; Kimura Y; Morimoto H; Suzuki T; Takahashi M Gan To Kagaku Ryoho; 1993 Apr; 20(6):737-40. PubMed ID: 7683864 [TBL] [Abstract][Full Text] [Related]
3. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Steck K; el-Naggar AK Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric evaluation of Ki67 proliferative antigen in primary breast cancer. Niezabitowski A; Lackowska B; Ryś J; Gruchała A; Szklarski W; Stelmach A; Wasilewska A; Kruczak A; Swiatkiewicz I Pol J Pathol; 1995; 46(1):17-22. PubMed ID: 7780692 [TBL] [Abstract][Full Text] [Related]
5. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306 [TBL] [Abstract][Full Text] [Related]
6. [Proliferative activity in gastric cancer with Ki-67 and propidium iodide: analysis by flow cytometry]. Kimura H; Yonemura Y; Ohyama S; Kamata T; Yamaguchi A; Miwa K; Miyazaki I Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):388-92. PubMed ID: 1603045 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [TBL] [Abstract][Full Text] [Related]
8. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry. Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786 [TBL] [Abstract][Full Text] [Related]
9. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content. Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238 [TBL] [Abstract][Full Text] [Related]
10. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542 [TBL] [Abstract][Full Text] [Related]
11. Quality control considerations for Ki-67 detection and quantitation in paraffin-embedded tissue. Hendricks JB; Wilkinson EJ J Cell Biochem Suppl; 1994; 19():105-10. PubMed ID: 7823581 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Albers P; Orazi A; Ulbright TM; Miller GA; Haidar JH; Donohue JP; Foster RS Mod Pathol; 1995 Jun; 8(5):492-7. PubMed ID: 7545814 [TBL] [Abstract][Full Text] [Related]
13. Washless double staining of unfixed nuclei for flow cytometric analysis of DNA and a nuclear antigen (Ki-67 or bromodeoxyuridine). Larsen JK; Christensen IJ; Christiansen J; Mortensen BT Cytometry; 1991; 12(5):429-37. PubMed ID: 1718672 [TBL] [Abstract][Full Text] [Related]
14. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics. Swanson SA; Brooks JJ Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714 [TBL] [Abstract][Full Text] [Related]
15. Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers. Henriksen R; Strang P; Backstrom T; Wilander E; Tribukait B; Oberg K Anticancer Res; 1994; 14(2B):603-8. PubMed ID: 8010717 [TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
17. Measurement of labeling index of DNA polymerase alpha in human brain tumors. Comparative study with labeling indices of BUdR in vitro and Ki-67. Nishizaki T; Orita T; Kamiryo T; Akimura T; Kajiwara K; Ikeda N; Ohshita N; Ito H; Sasaki K Clin Neuropathol; 1993; 12(3):160-3. PubMed ID: 8324965 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells. Landberg G; Roos G Cytometry; 1992; 13(3):230-40. PubMed ID: 1374305 [TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA)]. Ichikawa A; Shimamura K; Koyama Y Nihon Rinsho; 1992 Oct; 50(10):2343-8. PubMed ID: 1360029 [TBL] [Abstract][Full Text] [Related]
20. Little missed markers and Ki-67. Schwarting R Lab Invest; 1993 Jun; 68(6):597-9. PubMed ID: 8099985 [No Abstract] [Full Text] [Related] [Next] [New Search]